MiR-27a modulated MDR1/P-glycoprotein expression in human ovarian cancer cells by targeting HIPK2 [15] and could reverse the multidrug resistance of esophageal squamous cell carcinoma through regulation of MDR1 and apoptosis [14]. This evidence concerns the gene ABCB1 and ovarian carcinoma.